Three things to know:
1. Mr. Atkin succeeds Steve Savuk, who will continue to serve on the board.
2. Mr. Atkin has demonstrated expertise in leading technologies to commercialization and will be pivotal as Ortho RTI readies for its first U.S. clinical trial, according to President and CEO Claude LeDuc.
3. Ortho RTI develops tissue repair technologies to enhance the success rate of orthopedic and sports medicine surgeries.
More articles on devices:
7 celebrity spine surgeries and who performed them — Drs. Robert Watkins, Richard Guyer & more
The future of private practice and payers in spine: 3 key thoughts
Texas hospital suspends construction of $120M spine tower due to economic challenges
